A Study to Assess the Safety and Efficacy of Levodopa-carbidopa Intestinal Gel (LCIG) for the Treatment of Non-motor Symptoms in Patients With Advanced Parkinson's Disease
Clinical trial NCT01736176 · COMPLETED
Trial details
- NCT number
- NCT01736176
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2015-03-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.